Funding: Non-invasive renal ablation tech firm Kona Medical closes $40M Series C

Tue, 12/04/2012 - 11:38am
Mass Device

Kona Medical, maker of fully non-invasive ultrasound-based renal ablation technologies, closes a $40 million Series C round, bringing its total for the year to $70 million.

Kona Medical logo

Hypertension treatment devices maker Kona Medical closed a Series C funding round totaling $40 million in support of its ultrasound-based renal ablation systems.

Unlike other renal ablation systems, Kona's Surround Sound device uses external ultrasound to non-invasively target the nerves leading to and from the kidney, according to a press release.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.